Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A - Wikidata - thesis-toulmin - TriplyDB

Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A

Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A

http://www.wikidata.org/entity/Q35840042

about

The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo Collybolide is a novel biased agonist of κ-opioid receptors with potent antipruritic activity Identification of novel functionally selective κ-opioid receptor scaffolds.Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A Neoclerodanes as atypical opioid receptor ligands The 2-methoxy methyl analogue of salvinorin A attenuates cocaine-induced drug seeking and sucrose reinforcements in rats.Salvinorin A: A Mini Review of Physical and Chemical Properties Affecting Its Translation from Research to Clinical Applications in Humans.Kappa Opioid Receptor Agonist and Brain Ischemia.Salvinorin B meth-oxy-methyl ether.The C-2 derivatives of salvinorin A, ethoxymethyl ether Sal B and β-tetrahydropyran Sal B, have anti-cocaine properties with minimal side effects.The analgesic and anti-inflammatory effects of Salvinorin A analogue β-tetrahydropyran Salvinorin B in mice.Modular Approach to pseudo-Neoclerodanes as Designer κ-Opioid Ligands.

P2860

Q28249800-11EF5A66-59A1-477B-8EBA-F92A524F9670 Q28275440-F2A6E3F3-6361-4528-A3C2-48975DF9D065 Q34376764-49F9B20F-10F2-47A9-983D-3A6217BB9F1F Q34401390-9EE33EA2-927D-4E8E-8EF8-7DC5DC8F1E72 Q34796464-0596C26B-7D3B-423E-A5DE-E620C8C79B71 Q34939810-F434C417-9E24-473D-B4D1-C8884A81E171 Q36899819-0FEB3856-E6AC-4C14-8E16-8ADFDF2F74AD Q37507887-89A231F2-790E-46F1-A822-D952BDAC6C7F Q38262913-AD9B3A9F-E02B-4981-9FA1-FCFCE2DCF373 Q38312641-80EEDCED-740E-4219-AFC4-EFB1B7249DE0 Q42073472-90A5ED1B-FD67-44AF-81F0-B486F679CEF3 Q47878237-170175B8-B1B4-4653-8D65-49D804616D99 Q47977698-94949B01-6DDD-4EA9-BB4D-7FE6EEB8978A Q50591898-88C19023-53F1-4D53-956F-B2D5AC22CADD

P2860

Potential Drug Abuse Therapeutics Derived from the Hallucinogenic Natural Product Salvinorin A

http://www.wikidata.org/entity/Q35840042

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Potential Drug Abuse Therapeut ...... c Natural Product Salvinorin A

@ast

Potential Drug Abuse Therapeut ...... c Natural Product Salvinorin A

@en

type

label

Potential Drug Abuse Therapeut ...... c Natural Product Salvinorin A

@ast

Potential Drug Abuse Therapeut ...... c Natural Product Salvinorin A

@en

prefLabel

Potential Drug Abuse Therapeut ...... c Natural Product Salvinorin A

@ast

Potential Drug Abuse Therapeut ...... c Natural Product Salvinorin A

@en

P1433

Q35840042-341E965D-10FD-419F-96D9-3A9862B1BA2A

P1476

Q35840042-9EDF35EA-BEBB-4672-A713-D5D8A57765CB

P2093

Q35840042-2F09B259-7287-4848-8A1A-9FA38CF257E4

Q35840042-5EDE75F6-6C2D-4E2B-80FD-BD4CFC91E6D5

Q35840042-6223E789-4A6B-4F9D-9224-C2842CE9394D

Q35840042-8A8C108A-F943-4BEC-BDDF-5516020CA436

Q35840042-8C65179D-F30E-473A-9CF3-613D11A75B5F

Q35840042-8C876579-BE26-4573-AEDA-68A26A0C91A8

Q35840042-CCB0A7A4-4F79-48C6-AD28-A283FB3C0B38

Q35840042-DDAB1CB9-DC40-4D73-AEB4-2C91FB21F700

Q35840042-F510AB1A-D4F0-484F-971B-84AE09C4A393

P2860

Q35840042-0F6F23CA-3811-4FC6-BFAB-8026BB179EC5

Q35840042-11D6187E-F02F-4D3D-A9B6-7AD6B55EF365

Q35840042-152C3E3F-80B6-43CA-A637-4B96AFAF858E

Q35840042-21EC67A0-F43F-4BB4-8E25-1E7DF48FD03C

Q35840042-34B456BD-7B42-44C4-AD31-DA9DB0ED7D20

Q35840042-35DAA64A-BDAB-46E4-97D5-84D62E5DFD1A

Q35840042-39A604C3-AB4D-438F-BD0D-F38977720926

Q35840042-3ED627AF-84C7-4B2E-8A9F-9D554C2DD9E3

Q35840042-4721DE56-99C8-4384-BECA-8B678DB26AF8

Q35840042-5BC0D03F-0DDE-4CFB-91BB-3B8F33A0D320

P304

Q35840042-51FF96ED-ADC5-441C-BA3C-4B86A5CDF269

P31

Q35840042-43A16DE9-72B9-4F99-A996-1FCC1E501FF8

P356

Q35840042-4B0D65B0-9925-42E2-843C-50C3BE1D4FBD

P433

Q35840042-7F2C3C40-99AD-414F-AED2-537718F1D94D

P478

Q35840042-DFC0AB90-0701-4F5C-874A-3DE85847E543

P50

Q35840042-76AC9012-A3A9-4A99-8575-7F254E2977F8

P577

Q35840042-3E09B320-4DD4-4391-9089-290D7FC267D9

P698

Q35840042-0ACD692A-D62A-4DA6-BFBF-4B69C799C232

P932

Q35840042-4D4B776B-02C4-434A-BF2C-A87CE83F98F3

P356

P1433

P1476

Potential Drug Abuse Therapeut ...... c Natural Product Salvinorin A

@en

P2093

Christina M Dersch

http://www.w3.org/2001/XMLSchema#string

Denise S Simpson

http://www.w3.org/2001/XMLSchema#string

Justin T Douglas

http://www.w3.org/2001/XMLSchema#string

Katherine M Prevatt-Smith

http://www.w3.org/2001/XMLSchema#string

Kimberly M Lovell

http://www.w3.org/2001/XMLSchema#string

Peter Bosch

http://www.w3.org/2001/XMLSchema#string

Richard B Rothman

http://www.w3.org/2001/XMLSchema#string

Thomas E Prisinzano

http://www.w3.org/2001/XMLSchema#string

Victor W Day

http://www.w3.org/2001/XMLSchema#string

P2860

Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist

2-Methoxymethyl-salvinorin B is a potent kappa opioid receptor agonist with longer lasting action in vivo than salvinorin A

Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A

Kappa opioids as potential treatments for stimulant dependence

Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers

Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist

Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations

Ethnopharmacology of ska María Pastora (Salvia divinorum, Epling and Játiva-M.)

Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assay.

Salvia divinorum and salvinorin A: new pharmacologic findings.

P304

1217-1222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C1MD00192B

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Bronwyn M. Kivell

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22442751

http://www.w3.org/2001/XMLSchema#string

P932

3307802

http://www.w3.org/2001/XMLSchema#string